Search - tctmd.com

Displaying 21 - 40 of 71

Sort: Relevancy | Date

News Daily News

ACC/AHA Release Updated Aortic Disease Guideline

Todd Neale

November 02, 2022

News Conference News ESC 2022

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Shelley Wood

August 29, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Daily News

FDA Safety Communication Updates Stance on Endologix AAA Grafts

L.A. McKeown

January 13, 2022

News Daily News

People Age 90-Plus Do Fine With EVAR

Todd Neale

April 13, 2021

News Daily News

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Todd Neale

March 08, 2021

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Michael O'Riordan

January 07, 2020

News Daily News

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Yael L. Maxwell

January 02, 2019

News Conference News ESC 2018

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

L.A. McKeown

September 04, 2018

News Daily News

Women Likely Not Good Targets for AAA Screening, Study Suggests

Lucy Hicks

August 13, 2018

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Daily News

Sodium Fluoride Imaging in AAAs Provides a Picture of Future Risk

Caitlin E. Cox

January 30, 2018

News Daily News

Genetic Study Hints at Role of Lipids in AAA Risk

Michael O'Riordan

November 30, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

Advertisement

ACC/AHA Release Updated Aortic Disease Guideline

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

FDA Safety Communication Updates Stance on Endologix AAA Grafts

People Age 90-Plus Do Fine With EVAR

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

More Insights Into AAA Genetics Spur New Questions on Screening

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

Women Likely Not Good Targets for AAA Screening, Study Suggests

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

TCTMD’s Top 10 Most Popular Stories for February 2018

Next-Generation Large-Bore Closure Devices Arrive

Sodium Fluoride Imaging in AAAs Provides a Picture of Future Risk

Genetic Study Hints at Role of Lipids in AAA Risk

EVAR Outcomes Equivalent Between Men and Women, Registries Show

The Viborg Vascular (VIVA) Randomised Screening Trial

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content